What makes IGS2.7 a key molecule in the treatment of ALS is its pleiotropic effect, as it not only modulates mitophagy, but also has an important role in TDP-43 hyperphosphorylation and motor neuron preservation. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.